Athira Pharma, INC. (LONA) — 10-Q Filings

10-Q Filings (6)

• Athira Pharma Slashes Losses, Eyes Future Funding Amid Cash Burn — Nov 6, 2025 Risk: high
  Athira Pharma, Inc. (ATHA) reported a significant reduction in net loss and operating expenses for the nine months ended September 30, 2025, compared to the sam
• Athira Pharma Narrows Q2 Loss Amid R&D Streamlining — Aug 7, 2025 Risk: high
  Athira Pharma, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with its clinical-stage status. The company's net loss for
• Athira Pharma Files Q1 2025 10-Q — May 9, 2025 Risk: medium
  Athira Pharma, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial position and operational highlights, including detai
• Athira Pharma Files Q3 2024 10-Q — Nov 7, 2024 Risk: medium
  Athira Pharma, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial position and operational highlights. Key financi
• Athira Pharma Files Q2 2024 10-Q — Aug 1, 2024 Risk: medium
  Athira Pharma, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported research and development expenses for the six months ended June 30,
• Athira Pharma Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: low
  Athira Pharma, Inc. (LONA) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Athira Pharma, Inc. filed a 10-Q report for the period ending March 31,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX